Syra Health To Discuss Third Quarter 2024 Financial Results

Conference call will be held on Tuesday, October 29 at 9:00 AM ET

CARMEL, Ind., Oct. 22, 2024 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA), (“Syra Health” or the “Company”), a healthcare technology company powering better health by providing meaningful solutions, announced today that it will report financial results for the three months ended September 30, 2024, on Tuesday, October 29, 2024, before the market opens. The Company has scheduled a conference call that same day, October 29, at 9:00 a.m. ET, to review the results.

Interested parties can access the conference call via Internet webcast, which is available in the Investors section of the Company’s website at https://syrahealth.com/ir/presentations/q3-2024-earnings-call.

Investors who would like to submit a question to be addressed on the call should email the question to christined@syrahealth.com.

A webcast replay will be available in the Investors section of the Company’s website at https://syrahealth.com/ir/presentations/q3-2024-earnings-call.

ABOUT SYRA HEALTH CORP.
Syra Health leads the charge in addressing the toughest challenges in healthcare, from behavioral and mental health to population health, digital transformation, health education, and workforce development. Our technology-driven solutions focus on prevention, accessibility, and affordability, ensuring that every patient and provider gets the support they need. We proudly partner with payers, providers, life sciences organizations, academic institutions, and government entities to advance healthcare and improve outcomes. Learn more about our mission and services at www.syrahealth.com.

Contact
For Media or Investor Inquiries:
Christine Drury
Syra Health
IR/PR Director
463-345-5180
christined@syrahealth.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/syra-health-to-discuss-third-quarter-2024-financial-results-302282697.html

SOURCE Syra Health

Staff

Recent Posts

Vent Creativity Appoints Paul Abrams as Vice President of Sales to Lead Commercial Growth

NEW YORK--(BUSINESS WIRE)--Vent Creativity, a medical technology company advancing AI-enabled surgical planning, today announced the…

19 hours ago

AEON Clinic Announces Next Generation Medicine Congress 2026 Event: A Global Convergence on Human Longevity in Dubai

AEON Clinic Elevates Dubai to Global Hub for Longevity Science, A Definitive Four-Day Summit Defining…

19 hours ago

AI-Era Position Statement to Protect the Integrity of Healthcare, Technology, and Services Benchmarking published by Black Book Research

Black Book outlines an AI-era integrity architecture for healthcare benchmarking, instrumentation hardening, tiered verification, real-time…

2 days ago

New employee representative on the Board of Directors of Novo Nordisk A/S

Bagsværd, Denmark, 31 January 2026 – Thomas Rantzau, employee representative on the Board of Directors since…

2 days ago

Embers to Empowerment: The Womb Room Reopens in Govans, Expanding Community-Centered Perinatal Care After Hampden Fire

Baltimore, Maryland, Jan. 31, 2026 (GLOBE NEWSWIRE) -- After sustaining water damage during the massive…

2 days ago